Study of Edasalonexent With Midazolam and Deflazacort in Healthy Subjects
NCT04543370
·
clinicaltrials.gov ↗
PHASE1
Phase
COMPLETED
Status
26
Enrollment
INDUSTRY
Sponsor class
Conditions
Healthy
Interventions
DRUG:
Edasalonexent 2000 mg TID
DRUG:
Midazolam 2 MG/ML
DRUG:
Deflazacort 36Mg Tab
Sponsor
Catabasis Pharmaceuticals